Tuesday - February 17, 2026

IgA Nephropathy (IgAN) market across the 7MM is estimated at approximately USD 878 million in 2025, analyses DelveInsight

IgA Nephropathy market Leading companies such as Vertex Pharmaceuticals, Vera Therapeutics, Novartis, and AstraZeneca (Alexion Pharmaceuticals) are actively advancing new treatment options. The IgA Nephropathy (IgAN) market across the seven major markets (7MM) is estimated at approximately USD 878 million … Continue reading

Platinum-Resistant Ovarian Cancer Market to Surge by 2034 Across 7MM | 5+ Emerging Therapies and 60K+ Annual Cases Driving Innovation, Reports DelveInsight

Platinum-Resistant Ovarian Cancer Market The platinum-resistant ovarian cancer market is witnessing notable growth, fueled by significant unmet medical needs, as a substantial proportion of patients relapse following first-line platinum-based chemotherapy, thereby intensifying the demand for innovative second- and later-line therapeutic … Continue reading

Hemophilia B Market to Surpass USD 3.4 Billion in 7MM, with 5+ Emerging Therapies and Gene Therapy Advancements Driving Growth Through 2034, states DelveInsight

Hemophilia B Market Major companies operating in the Hemophilia B space include UniQure Biopharma B.V., CSL Behring, Pfizer/Spark Therapeutics, Genzyme (a Sanofi company), Alnylam Pharmaceuticals, Novo Nordisk, ApcinteX Ltd, Freeline Therapeutics, Sangamo Therapeutics, and others. Hemophilia B Market Overview In … Continue reading